We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+7.37%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
AUM
$9.69B
AUM Growth
+$805M
Cap. Flow
+$420M
Cap. Flow %
4.33%
Top 10 Hldgs %
28.55%
Holding
286
New
47
Increased
108
Reduced
76
Closed
36

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$77M
2
AMGN icon
Amgen
AMGN
+$72.2M
3
AET
Aetna Inc
AET
+$65.7M
4
CELG
Celgene Corp
CELG
+$54.3M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$52.8M

Sector Composition

Rank Sector Weight
1 Financials 21.51%
2 Healthcare 20.26%
3 Technology 19.08%
4 Communication Services 10.55%
5 Industrials 6.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JAZZ icon
251
Jazz Pharmaceuticals
JAZZ
$15.9B
-361,018
Closed -$52.8M
LIVN icon
252
LivaNova
LIVN
$4.3B
-191,219
Closed -$13.4M
MCO icon
253
Moody's
MCO
$81.7B
-17,212
Closed -$2.4M
MTSI icon
254
MACOM Technology Solutions
MTSI
$20.4B
-355,622
Closed -$15.9M
NGD
255
DELISTED
New Gold Inc
NGD
-2,654,392
Closed -$9.86M
PAYC icon
256
Paycom
PAYC
$6.78B
-147,910
Closed -$11.1M
PEP icon
257
PepsiCo
PEP
$186B
-691,451
Closed -$77M
RL icon
258
Ralph Lauren
RL
$22.2B
-137,229
Closed -$12.1M
SPY icon
259
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$781B
-2,767,500
Closed -$695M
SSTI icon
260
SoundThinking
SSTI
$107M
-97,868
Closed -$1.31M
WDAY icon
261
Workday
WDAY
$33.4B
-73,508
Closed -$7.75M
RVNC
262
DELISTED
Revance Therapeutics, Inc.
RVNC
-1,424,213
Closed -$39.2M
AUY
263
DELISTED
Yamana Gold, Inc.
AUY
-1,202,181
Closed -$3.28M
ABMD
264
DELISTED
Abiomed Inc
ABMD
-210,000
Closed -$35.4M
TWTR
265
DELISTED
Twitter, Inc.
TWTR
-106,125
Closed -$1.79M
TVTY
266
DELISTED
Tivity Health, Inc. Common Stock
TVTY
-663,100
Closed -$27.1M
ARNA
267
DELISTED
Arena Pharmaceuticals Inc
ARNA
-150,000
Closed -$3.83M
KL
268
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
$0 ﹤0.01%
+2,501,907
New +$34.4M
TLND
269
DELISTED
Talend S.A. American Depositary Shares
TLND
-485,007
Closed -$19.8M
CALD
270
DELISTED
Callidus Software, Inc.
CALD
-117,388
Closed -$2.89M
RXDX
271
DELISTED
Ignyta, Inc.
RXDX
-375,000
Closed -$4.63M
BSFT
272
DELISTED
BroadSoft, Inc.
BSFT
-37,396
Closed -$1.88M
ESV
273
DELISTED
Ensco Rowan plc
ESV
-26,610
Closed -$635K

Similar funds

Polar Capital's Q4 2017 Portfolio in Review

As of Q4 2017, Polar Capital held 286 positions worth $9.69B, up 9.1% from $8.89B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Polar Capital deployed $420M of net new capital in Q4 2017, opening 47 new positions and adding to 108 existing holdings. Its largest new stake was Alnylam Pharmaceuticals: 516,232 shares worth $65.6M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Aetna Inc, an estimated $65.7M trimmed.

  • Polar Capital's largest Q4 2017 buy was Alnylam Pharmaceuticals: 516,232 shares worth $65.6M.
  • Polar Capital added most to Microsoft in Q4 2017, an estimated $93.3M increase.
  • Polar Capital's biggest Q4 2017 reduction was Aetna Inc, cutting an estimated $65.7M.
  • Polar Capital fully exited PepsiCo in Q4 2017, selling an estimated $77M.
  • Polar Capital's ten largest holdings make up 29% of its $9.69B portfolio in Q4 2017.
  • Polar Capital opened 47 new positions and closed 36 in Q4 2017.
  • Polar Capital's portfolio value rose 9.1% quarter-over-quarter to $9.69B.

Based on Polar Capital's 13F filing for Q4 2017, filed 14 Feb 2018.